• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • Biomarkers
    • ResearchMatch (RM)
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • R25 Clinical Research Experiential Summer Training (CREST)
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • I want to start a clinical trial
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page

Rutgers Recruiting Participants for Johnson & Johnson Phase 3 COVID-19 Vaccine Clinical Trial

by William Jester | Dec 18, 2020 | Community, Covid, News

Rutgers University is a clinical trial site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s phase 3 clinical research study to evaluate the safety and efficacy of Janssen’s COVID-19 vaccine candidate. Rutgers will enroll as many as 2,000...

New At-Home Covid Test Gets Green Light From F.D.A.

by William Jester | Dec 18, 2020 | Community, Covid, News

The Food and Drug Administration on Tuesday issued an emergency authorization for the country’s first coronavirus test that can run from start to finish at home without the need for a prescription. People as young as 2 years old are cleared to use the test, which...

COVID Vaccinations For New Jersey Health Care Workers To Begin Tuesday

by William Jester | Dec 17, 2020 | Community, Covid, News

The first COVID vaccines in New Jersey will be administered to health care workers in Newark on Tuesday, Gov. Phil Murphy announced Sunday. In anticipation of vaccine shipments, University Hospital set up a COVID-19 vaccine clinic at Rutgers New Jersey Medical School...

Coronavirus Vaccine Clinic Begins at Rutgers New Jersey Medical School

by William Jester | Dec 17, 2020 | Community, Covid, News

Robert Johnson, dean of Rutgers’ two medical schools, was among the first people in New Jersey to receive the vaccine against COVID-19 on a historic day in the fight against a virus that has crippled the nation since last spring. Johnson, dean of Rutgers New Jersey...
She was principal investigator of Moderna COVID-19 vaccine trial in Newark. Her insights will inform you

She was principal investigator of Moderna COVID-19 vaccine trial in Newark. Her insights will inform you

by William Jester | Dec 17, 2020 | Community, Covid, News

Dr. Shobha Swaminathan is an associate professor at Rutgers New Jersey Medical School and medical director of infectious diseases practice at University Hospital. This week, she is better known for being the principal investigator for the Moderna Phase 3 coronavirus...
« Older Entries
Next Entries »

Recent Posts

  • NIH Fellowship Writing Group: Call for Applications – Sign Up by 8/25
  • Join The National Clinical Cohort Collaborative (N3C) Community Forum on 7/30
  • NIH Fellowship Writing Group: Call for Applications – Sign Up by 8/25
  • Rutgers Students Showcase AI-Driven Research Success Through NJ ACTS Summer Research Program
  • Rutgers NJHealth Study Data Access Opportunity – Application Due July 6th!

Archives

  • 2026
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2025
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,500)
  • Covid (1,001)
  • CTO Events (6)
  • News (3,174)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.